EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

CERVICAL CANCER ASSOCIATED WITH EXTERNALIZED GENITAL PROLAPSE: ABOUT 02 CASES

Mossé B. A. Wilfried*, Mouhcine Hommadi, N’da Guy, El-Abbassi Sara, Hanan El-Kacemi, Tayeb Kebdani, Sanaa El-Majjaoui and Noureddine Benjaafar

ABSTRACT

The treatment of cervical cancer has been protocolled, but the management of uterovaginal prolapse associated with carcinoma of the cervix is not standardized and therapy strategies vary considerably among authors. We report a 58-year-old woman presenting a prolapse genital evolving for 2 years and neglected by the patient. Allowed in our department in January 2018. The physical examination found a hysterocele of stage III according to the classification of ICS POP-Q. Cervical biopsies were carried out and examination histopathologic revealed a well-differentiated and invasive carcinoma epidermoid. The pelvic scanner with an injection of a product of contrast showed: a bulky urogenital prolapse with rectocele, cystocele and elytrocele, FIGO IVA. She underwent Concomitant radio chemotherapy. After a multidisciplinary conciliation meeting, taking into account the character locally advanced, a surgery of correction was proposed. Second case: a-79-year-old female presented with 11 months history of post-menopausal bleeding, pelvic pain and sensation of heaviness which was increasing in intensity over than 8 months. Physical assessment showed a large genital prolapse third degree and ulcerous and necrotic lesion at the lower part prolapse. Histopathological examination of cervical biopsies revealed well differentiated and invasive squamous cell carcinoma. She was staging according to the International Federation of Gynecology and Obstetrics staging system 2009 as FIGO IIIB. The patient was treated by palliative chemotherapy. After 3 months, the patient died. Conclusion: The rarity of this association explains the difficulties of care encountered and its pathogeny has poorly known hence the importance of multidisciplinary consultation.

Keywords: Genital prolapse; Cervix carcinoma; Surgery; Radiotherapy.

[Full Text Article] [Download Certificate]